DG DISPATCH - AACAP: Risperidone May Treat Aggression In Youths
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - AACAP: Risperidone May Treat Aggression In Youths

By Lara Pullen
Special to DG News

CHICAGO, IL -- October 27, 1999 -- An increasing amount of research is being done on the treatment of bipolar disorder in children and adolescents. A recent study indicates that risperidone might be useful in the treatment of aggression in youths with bipolar disorder.

At the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry, Dr. Jean A. Frazier, of Massachusetts General Hospital, in Boston, presented the results of a recently completed treatment study of juvenile bipolar disorder. The study examined the effects of risperidone, an atypical antipsychotic, which has had mixed results in the treatment of adults with bipolar disorder.

The study was a retrospective chart review designed to address the psychopharmacology of aggression. The 28 children in the study had bipolar disorder and were being treated with risperidone (2.5 - 20 mg/day) in an academic setting.

The results showed significant improvement in symptoms of mania (82 percent), psychosis (69 percent) and aggression (82 percent). The side effects included weight gain and sedation.

Dr. Frazier said that the results of this study and others show that atypical antipsychotics hold much promise in the long-term treatment of high psychosis and bipolar disorder in children. She recommends further studies to look at the effect of these drugs on cognition as preliminary data suggest they may actually improve cognition.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities